Plexus Corp. announced it will release its fiscal fourth quarter and full year 2026 earnings after market close on October 28, 2026. The company's management will hold a conference call to discuss these results on October 29, 2026, at 8:30 a.m. Eastern Time. Investors can access the live webcast and slides on Plexus' investor relations website. This event provides insight into Plexus' financial performance and outlook for the year.
Plexus Corp.'s upcoming fiscal fourth quarter and full year 2026 earnings release is noted here with Industrials sector market data for context. For readers following Industrials, as of Oct 15, 2026 03:11 WIB, out of 136 priced US Industrials stocks on Pluang, 41 rose and 95 fell. Notable movers include CMBT at USD 18.89 with a 1-day change of -9.14%, FuelCell Energy Inc (FCEL) at USD 14.16 down 8.58%, and T1 Energy Inc. (TE) at USD 2.89 down 8.54%.
Stephany Insurance LLC, a fourth-generation independent agency in Wexford, PA, is highlighted in a new 2026 guide for helping small businesses in Pittsburgh's North Hills identify and close insurance coverage gaps caused by rising premiums. The guide...
The Knowles-Rowland House, a $13.96 million redevelopment project by Bread of Life Inc., has opened in Midtown Houston, providing 31 permanent supportive housing units for individuals exiting chronic homelessness. The building, formerly a fire-damage...
ATLAS SP Partners, majority owned by Apollo funds, announced the pricing of $750 million senior notes due 2032 with a fixed 6.25% interest rate until November 2031, then switching to a floating rate based on SOFR plus a spread. The notes, issued by A...
Bending Spoons led market gainers with a 41.2% rise after Berkshire Hathaway increased its stake to 4% by investing an additional $330 million. Antelope Enterprise gained 36.4%, and NEXGEL rose 32.1% following a reverse stock split. Liquidia advanced...
The Law Offices of Frank R. Cruz is investigating Alignment Healthcare following a whistleblower lawsuit claiming the company misclassified $8-10 million in expenses to inflate its adjusted EBITDA and stock price. This alleged accounting manipulation...
